Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £239.60m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Acquisition

16 Sep 2015 11:10

RNS Number : 2314Z
Science Group PLC
16 September 2015
 

 

16 September 2015

 

 

Science Group plc

("Science Group" or the "Group")

 

Acquisition of Business and Assets of Leatherhead Food International Limited

 

Science Group plc (AIM:SAG) has acquired the operating business and assets, excluding the freehold property, of Leatherhead Food International Limited ("Leatherhead"), a technical consultancy providing scientific research, regulatory advice, market insights, testing and other services to the food and drink industry. Founded in 1919, Leatherhead provides science-based services to an international customer base of over 500 clients, including major global food manufacturers and major UK retailers. In the year to 31 December 2013, the last filed audited accounts, Leatherhead reported revenue of £8.8 million and a profit before tax of £0.1 million. Leatherhead currently employs approximately 150 staff. Information on Leatherhead can be found at www.leatherheadfood.com.

 

As a result of a cash flow shortfall and a significant legacy pension scheme deficit, the Board of Leatherhead, with its advisors, conducted a process to find an investment partner. The Science Group was included in this process due to prior contact having been established through the Group's acquisition activities. As a result, SGL1 Limited, a wholly owned subsidiary of Science Group plc, has now acquired the operating business and assets (excluding the freehold property and free of debt and DB pension liabilities) from the Administrator of Leatherhead, for £1.625 million payable in cash. It is anticipated that SGL1 Limited will be renamed Leatherhead Research Limited.

 

The acquisition of the Leatherhead business is highly complementary to the Consumer market sector activities of Sagentia (the Science Group's core science and technology development business) and with Oakland Innovation, acquired in February 2015. Both of these businesses have an established presence with major food and drink companies and Science Group has seen increasing investment from this market sector in science-based services. The acquisition of the Leatherhead business, a very well established brand in the food and drink market, further strengthens the Group's capabilities in this high profile and exciting industry.

 

The Leatherhead operations will vacate the current premises and relocate to a new facility in the first half of 2016. This new facility will establish a hub for the Science Group's operations south of London, complementing the existing Harston, Cambridge facility.

 

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Rebecca Hemsted, Finance Director

www.sagentia.com

 

Numis Securities Limited

Nominated Adviser: Oliver Cardigan / Simon Willis

Corporate Broking: James Serjeant

Tel: +44 (0) 20 7260 1000

 

Media enquiries:

Abchurch

Jamie Hooper

Tel: +44 (0) 20 7398 7719

jamie.hooper@abchurch-group.com

www.abchurch-group.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQGGUQUBUPAGUQ
Date   Source Headline
11th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:01 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTreasury shares issued
1st Jun 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:01 amRNSTransaction in Own Shares
27th May 20267:00 amRNSIssue of share options and PDMR dealing
22nd May 20267:00 amRNSTreasury Shares Issued
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20261:05 pmRNSResult of Annual General Meeting
20th May 20267:01 amRNSAGM Trading Update and Capital Allocation
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:01 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTreasury Shares Issued
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:01 amRNSNotice of Annual General Meeting
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTreasury Shares Issued
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.